VP4896
IA0084
Phase 3 small_molecule completed
Quick answer
VP4896 for Alzheimer's Disease is a Phase 3 program (small_molecule) at Voyager Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Voyager Therapeutics
- Indication
- Alzheimer's Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed